1. Home
  2. WTFC vs EXAS Comparison

WTFC vs EXAS Comparison

Compare WTFC & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WTFC
  • EXAS
  • Stock Information
  • Founded
  • WTFC 1991
  • EXAS 1995
  • Country
  • WTFC United States
  • EXAS United States
  • Employees
  • WTFC N/A
  • EXAS N/A
  • Industry
  • WTFC Major Banks
  • EXAS Medical Specialities
  • Sector
  • WTFC Finance
  • EXAS Health Care
  • Exchange
  • WTFC Nasdaq
  • EXAS Nasdaq
  • Market Cap
  • WTFC 8.9B
  • EXAS 9.1B
  • IPO Year
  • WTFC N/A
  • EXAS N/A
  • Fundamental
  • Price
  • WTFC $127.09
  • EXAS $45.60
  • Analyst Decision
  • WTFC Strong Buy
  • EXAS Strong Buy
  • Analyst Count
  • WTFC 14
  • EXAS 22
  • Target Price
  • WTFC $147.86
  • EXAS $66.43
  • AVG Volume (30 Days)
  • WTFC 436.4K
  • EXAS 3.9M
  • Earning Date
  • WTFC 07-21-2025
  • EXAS 08-06-2025
  • Dividend Yield
  • WTFC 1.57%
  • EXAS N/A
  • EPS Growth
  • WTFC 10.01
  • EXAS N/A
  • EPS
  • WTFC 10.58
  • EXAS N/A
  • Revenue
  • WTFC $2,480,496,000.00
  • EXAS $2,939,949,000.00
  • Revenue This Year
  • WTFC $16.74
  • EXAS $14.61
  • Revenue Next Year
  • WTFC $5.47
  • EXAS $12.71
  • P/E Ratio
  • WTFC $12.02
  • EXAS N/A
  • Revenue Growth
  • WTFC 11.93
  • EXAS 12.55
  • 52 Week Low
  • WTFC $89.10
  • EXAS $38.81
  • 52 Week High
  • WTFC $142.04
  • EXAS $72.83
  • Technical
  • Relative Strength Index (RSI)
  • WTFC 49.26
  • EXAS 44.47
  • Support Level
  • WTFC $126.12
  • EXAS $40.55
  • Resistance Level
  • WTFC $128.75
  • EXAS $45.45
  • Average True Range (ATR)
  • WTFC 2.77
  • EXAS 2.04
  • MACD
  • WTFC -0.18
  • EXAS 0.07
  • Stochastic Oscillator
  • WTFC 40.03
  • EXAS 63.10

About WTFC Wintrust Financial Corporation

Wintrust Financial Corp is a financial holding company that provides community-oriented, personal, and commercial banking services to customers generally located in the Chicago metropolitan area, southern Wisconsin, northwest Indiana, and western Michigan. The company provides specialty finance services, including financing for the payment of property and casualty insurance premiums and life insurance premiums, and wealth management services to customers in its market area. The company's operations consist of three primary segments: community banking, specialty finance, and wealth management. The company generates the majority of its revenue from the community banking segment.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: